Dare Bioscience Inc. (DARE): A Technical View

As of Thursday close, Dare Bioscience Inc.’s (NASDAQ:DARE) stock was up $0.09, moving up 9.56 percent to $1.03. The average number of shares traded per day over the past five days has been 1,152,000 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0900 fall in that time frame. In the last twenty days, the average volume was 1,072,165, while in the previous 50 days, it was 1,577,982.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Since last month, DARE stock retreated -25.36%. Shares of the company fell to $0.9201 on 05/12/22, the lowest level in the past month. A 52-week high of $2.51 was reached on 01/04/22 after having rallying from a 52-week low of $0.92. Since the beginning of this year, DARE’s stock price has dropped by -48.50% or -$0.9700, and marked a new high 2 times. However, the stock has declined by -58.96% since its 52-week high.

Financial Health

In the three months ended September 29, Dare Bioscience Inc.’s quick ratio stood at 3.40, while its current ratio was 3.40, showing that the company is able to pay off its debt.

While analysts expected Dare Bioscience Inc. to report -$0.13 quarterly earnings, the actual figure was -$0.18 per share, beating the consensus estimate by -38.50%. The liabilities of Dare Bioscience Inc. were 17.05 million at the end of its most recent quarter ended September 29, and its total debt was $0.38 million. The value of shareholders’ equity is $83.94 million.

Technical Picture

This quick technical analysis looks at Dare Bioscience Inc.’s (DARE) price momentum. With a historical volatility rate of 86.99%, the RSI 9-day stood at 35.41% on 12 May.

With respect to its five-day moving average, the current Dare Bioscience Inc. price is down by -8.04% percent or -$0.0900. At present, DARE shares trade -26.95% below its 20-day simple moving average and -41.81% percent below its 100-day simple moving average. However, the stock is currently trading approximately -30.41% below its SMA50 and -31.33% below its SMA200.

Stochastic coefficient K was 15.25% and Stochastic coefficient D was 10.18%, while ATR was 0.0830. Given the Stochastic reading of 32.33% for the 14-day period, the RSI (14) reading has been calculated as 33.97%. As of today, the MACD Oscillator reading stands at -0.0755, while the 14-day reading stands at -0.1078.

Analyst Ratings

Dare Bioscience Inc. (DARE) has been rated Buy by analysts. According to 0 brokerage firms, DARE is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Dare Bioscience Inc. stock as buy, with 5 recommending it as overweight.

With a median target price of $6.00, the current consensus forecast for the stock is $3.00 – $17.00. Based on these forecasts, analysts predict Dare Bioscience Inc. (DARE) will achieve an average price target of $7.20.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles